BIXT / Bioxytran, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Bioxytran, Inc.
US ˙ OTCPK

Ações em Circulação 114,195,220 shares
Ações de Insider116,982,942 shares
Total de Insiders18
Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

0 ( )
6238 out of 10931

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

0.000% ( )
6111 out of 10786

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Bioxytran, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Afcc, Llc - 2,350,000 2,350,000
Bonafide Lawrence W. Director - [D] 8,753,716 8,753,716
Dale H Conaway Director - [D] 379,177 379,177
Hana Chen-Walden Director - [D] 0 0
Dennis Cullison President/Treasurer, Director, 10% Owner - [D] [O] [10%] 22,769,118 22,769,118
Dave Quincy Farber President, Director - [D] [O] 7,200,000 7,200,000
Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Paul W Hait 10% Owner - [10%] 21,567,769 21,567,769
Hait Paul W. 10% Owner - [10%] 1,791,776 1,791,776
Alan M Hoberman Director - [D] 210,000 210,000
Kendig Donita R. Secretary/Treasurer, Director - [D] [O] 7,500,000 7,500,000
David Lee Director - [D] 3,204,000 3,204,000
Radka Milanova Director - [D] 203,688 203,688
Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Nathan Marks Director - [D] 3,008,326 3,008,326
Binder Offer 10% Owner - [10%] 8,919,169 8,919,169
David Platt CEO, Director, 10% Owner - [D] [O] [10%] 20,038,903 20,038,903
Michael Sheikh CCO, 10% Owner - [O] [10%] 8,214,720 8,214,720
Ola Soderquist CFO, 10% Owner - [O] [10%] 500,000 500,000
Anders Utter Director - [D] 372,580 372,580

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em BIXT / Bioxytran, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Máx
Preço em
Máx
Lucro
Máximo ($)
Retorno Máximo (%)
2025-11-18 Hoberman Alan M 210,000 0.6000 210,000 0.6000 126,000 730
2024-08-15 PLATT DAVID 1,592,921 0.1240 1,592,921 0.1240 197,522

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

BIXT / Bioxytran, Inc. Insider Trades
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em BIXT / Bioxytran, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2014-03-17 HAIT PAUL W 95,225 0.0400 95,225 0.0400 3,809 731 0.0490 857 22.50
2014-03-14 HAIT PAUL W 4,775 0.0400 4,775 0.0400 191
2013-11-15 HAIT PAUL W 54,953 0.0958 54,953 0.0958 5,264
2013-10-21 HAIT PAUL W 100,000 0.1000 100,000 0.1000 10,000

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

BIXT / Bioxytran, Inc. Insider Trades
Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo
Data
Data da
Operação
Formulário Insider Ticker Título de Segurança Código 10b5-1 Direto Preço de Exercício
Preço Unitário
Preço por
Unidade
Unidades
Alteradas
Valor
Alterado (1K)
Opções
Restantes
Ações
Restantes
2025-11-18 2025-11-18 4 Hoberman Alan M BIXT common P - Purchase D 0.6000 210,000 126 210,000
2025-11-18 2025-11-14 4 Hoberman Alan M BIXT preferred A - Award D 0.3500 38,588 14 416,207
2025-11-18 2025-08-12 4 Hoberman Alan M BIXT preferred A - Award D 0.4850 10,417 5 377,619
2025-11-18 2025-11-14 4 MILANOVA RADKA BIXT preferred A - Award D 0.3500 38,588 14 203,688
2025-11-18 2025-08-12 4 MILANOVA RADKA BIXT preferred A - Award D 0.4850 10,417 5 165,100
2025-11-18 2025-11-14 4 CONAWAY DALE H BIXT preferred A - Award D 0.3500 38,588 14 379,177
2025-11-18 2025-08-12 4 CONAWAY DALE H BIXT preferred A - Award D 0.4850 10,417 5 340,589
2025-11-18 2025-11-14 4 Utter Anders BIXT preferred A - Award D 0.3500 38,588 14 372,580
2025-11-18 2024-10-24 4/A PLATT DAVID BIXT preferred J - Other D 0.5450 11,433,448 6,231 20,038,903
2025-11-18 2024-10-24 4/A PLATT DAVID through NDPD Pharma BIXT preferred J - Other I 0.2850 -14,085,410 -4,014 0
2025-11-18 2024-10-25 4/A Sheikh Michael BIXT preferred J - Other D 0.5450 6,614,720 3,605 8,214,720
2025-11-18 2024-10-25 4/A Soderquist Ola BIXT common J - Other D 0.0010 500,000 0 500,000
2025-11-18 2024-10-25 4/A Soderquist Ola BIXT preferred J - Other D 0.0050 100,000 0 13,876,456
2025-11-18 2024-10-25 4/A Soderquist Ola BIXT preferred J - Other D 0.5450 10,069,396 5,488 13,976,456
2025-01-14 2025-01-06 4 MILANOVA RADKA BIXT Preferred A - Award D 0.3150 97,535 31 154,683
2025-01-14 2025-01-06 4 CONAWAY DALE H BIXT Preferred A - Award D 0.3150 97,535 31 330,172
2025-01-14 2025-01-06 4 Hoberman Alan M BIXT Preferred A - Award D 0.3150 97,535 31 367,202
2025-01-14 2025-01-06 4 Utter Anders BIXT preferred A - Award D 0.3150 97,535 31 333,992
2024-10-28 2024-10-25 4 MILANOVA RADKA BIXT preferred A - Award D 0.4600 20,619 9 57,148
2024-10-28 2024-10-25 4 PLATT DAVID BIXT Preferred J - Other D 0.5450 11,190,077 6,099 19,795,532
2024-10-28 2024-10-25 4 PLATT DAVID through NDPD Pharma BIXT Preferred J - Other I 0.2850 -14,085,410 -4,014 0
2024-10-28 2024-10-25 4 Utter Anders BIXT preferred A - Award D 0.4600 20,619 9 236,457
2024-10-28 2024-10-24 4 Sheikh Michael BIXT Preferred J - Other D 0.5450 6,473,921 3,528 8,073,921
2024-10-28 2024-10-25 4 CONAWAY DALE H BIXT preferred A - Award D 0.4600 20,619 9 232,637
2024-10-28 2024-10-25 4 Soderquist Ola BIXT common J - Other D 0.0010 500,000 0 500,000
2024-10-28 2024-10-25 4 Soderquist Ola BIXT preferred J - Other D 0.0050 -100,000 -0 14,004,671
2024-10-28 2024-10-25 4 Soderquist Ola BIXT preferred J - Other D 0.5450 10,197,611 5,558 14,104,671
2024-10-28 2024-10-25 4 Hoberman Alan M BIXT preferred A - Award D 0.4600 20,619 9 269,667
2024-08-20 2024-08-19 4 Soderquist Ola BIXT preferred J - Other D 0.0500 3,907,060 195 3,907,060
2024-08-20 2024-08-19 4 Soderquist Ola BIXT common J - Other D 0.0010 -19,535,300 -20 0
2024-08-20 2024-08-19 4 Sheikh Michael BIXT preferred J - Other D 0.0150 1,600,000 24 1,600,000
2024-08-20 2024-08-19 4 Sheikh Michael BIXT common J - Other D 0.0030 -8,000,000 -24 0
2024-08-20 2024-08-19 4 MILANOVA RADKA BIXT preferred J - Other D 0.6550 36,529 24 36,529
2024-08-20 2024-08-19 4 MILANOVA RADKA BIXT common J - Other D 0.1310 -182,645 -24 0
2024-08-20 2024-08-16 4 MILANOVA RADKA BIXT common A - Award D 0.1210 82,645 10 182,645
2024-08-20 2024-08-19 4 PLATT DAVID BIXT preferred J - Other D 0.0050 8,605,455 43 8,605,455
2024-08-20 2024-08-19 4 PLATT DAVID BIXT common J - Other D 0.0010 -43,027,274 -43 0
2024-08-20 2024-08-19 4 PLATT DAVID by Naomi Platt BIXT preferred J - Other I 0.0050 82,260 0 82,260
2024-08-20 2024-08-19 4 PLATT DAVID by Naomi Platt BIXT common J - Other I 0.0010 -411,300 -0 0
2024-08-20 2024-08-19 4 PLATT DAVID by NDPD Pharma BIXT preferred J - Other I 0.4560 776,817 354 14,085,410
2024-08-20 2024-08-19 4 PLATT DAVID by NDPD Pharma BIXT preferred C - Conversion I 0.0180 8,973,405 162 13,308,593
2024-08-20 2024-08-19 4 PLATT DAVID by NDPD Pharma BIXT preferred J - Other I 0.8060 4,335,188 3,494 4,335,188
2024-08-20 2024-08-19 4 PLATT DAVID by NDPD Pharma BIXT common J - Other I 0.1620 -21,675,939 -3,512 0
2024-08-20 2024-08-15 4 PLATT DAVID by NDPD Pharma BIXT common P - Purchase I 0.1240 1,592,921 198 21,675,939
2024-08-20 2024-08-19 4 Utter Anders BIXT preferred J - Other D 0.8250 215,838 178 215,838
2024-08-20 2024-08-19 4 Utter Anders BIXT common J - Other D 0.1650 -1,079,189 -178 0
2024-08-20 2024-08-16 4 Utter Anders BIXT common A - Award D 0.1210 123,967 15 1,079,189
2024-08-20 2024-08-19 4 CONAWAY DALE H BIXT preferred J - Other D 0.8350 212,018 177 212,018
2024-08-20 2024-08-19 4 CONAWAY DALE H BIXT common J - Other D 0.1670 1,060,089 177 0
2024-08-20 2024-08-16 4 CONAWAY DALE H BIXT common A - Award D 0.1210 123,967 15 1,060,089
2024-08-20 2024-08-19 4 Hoberman Alan M BIXT preferred J - Other D 0.7950 226,678 180 226,678
2024-08-20 2024-08-19 4 Hoberman Alan M BIXT common J - Other D 0.1590 -1,133,389 -180 0
2024-08-20 2024-08-16 4 Hoberman Alan M BIXT common A - Award D 0.1210 123,967 15 1,133,389
2024-04-19 2024-04-19 4 MILANOVA RADKA BIXT common A - Award D 0.1420 70,423 10 955,222
2024-04-19 2024-04-19 4 CONAWAY DALE H BIXT common A - Award D 0.1420 70,423 10 936,122
2024-04-19 2024-04-19 4 Hoberman Alan M BIXT common A - Award D 0.1420 70,423 10 1,009,422
2024-04-19 3 MILANOVA RADKA BIXT common D 100,000
2024-03-27 2024-03-27 4 Utter Anders BIXT common A - Award D 0.1140 266,955 30 874,576
2024-03-27 2024-03-27 4 CONAWAY DALE H BIXT common A - Award D 0.1140 266,955 30 855,476
2024-03-27 2024-03-27 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common A - Award I 0.1040 439,595 46 20,133,018
2024-03-27 2024-03-27 4 Hoberman Alan M BIXT common A - Award D 0.1140 266,955 30 928,776
2024-01-16 2023-10-31 5 Utter Anders BIXT common stock A - Award D 0.1420 77,721 11 607,621
2024-01-16 2023-10-31 5 CONAWAY DALE H BIXT common stock A - Award D 0.1420 77,721 11 607,621
2024-01-16 2023-10-31 5 Hoberman Alan M BIXT common stock A - Award D 0.1420 77,721 11 661,821
2024-01-16 2024-01-16 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common stock A - Award I 0.1350 3,599,289 486 19,693,423
2024-01-16 2023-10-01 5 Chen-Walden Hana BIXT Stock Option Plan 2010 H - Other D 0.0500 -3,000 -0 0
2023-11-02 2023-10-31 4 CONAWAY DALE H BIXT common A - Award D 0.1930 77,721 15 588,521
2023-11-02 2023-10-31 4 Utter Anders BIXT common A - Award D 0.1930 77,721 15 607,621
2023-11-02 2023-10-31 4 Hoberman Alan M BIXT common A - Award D 0.1930 77,721 15 661,821
2023-09-15 2023-09-14 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common A - Award I 0.1350 5,824,741 786 16,094,134
2023-08-24 2023-08-21 4 PLATT DAVID by NDPD Pharma, Inc. bixt common stock G - Gift I 0.3200 500,000 160 10,269,393
2023-08-24 2023-08-04 4 CONAWAY DALE H bixt common stock A - Award D 0.1500 40,000 6 510,800
2023-08-24 2023-08-04 4 Utter Anders bixt common stock A - Award D 0.1500 40,000 6 529,900
2023-08-24 2023-08-04 4 Hoberman Alan M BIXT common stock A - Award D 0.1500 40,000 6 584,100
2023-05-17 2023-05-17 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common G - Gift I 0.3200 -92,000 -29 19,535,300
2023-05-17 2023-05-17 4 Soderquist Ola BIXT common G - Gift D 0.0010 -50,000 -0 19,535,300
2023-05-17 2023-05-17 4 Sheikh Michael BIXT common G - Gift D 0.0030 -800,000 -2 8,000,000
2023-05-10 2023-04-14 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common A - Award I 0.3200 6,763,562 2,164 10,861,393
2023-05-04 2023-04-18 4 CONAWAY DALE H BIXT Common Stock A - Award D 0.4480 30,000 13 470,800
2023-05-04 2023-04-18 4 Utter Anders BIXT Common Stock A - Award D 0.4480 30,000 13 489,900
2023-05-04 2023-04-18 4 Chen-Walden Hana BIXT Common Stock A - Award D 0.4800 20,000 10 367,800
2023-05-04 2023-04-18 4 Hoberman Alan M BIXT Common Stock A - Award D 0.4340 50,000 22 544,100
2023-02-08 2022-11-21 4 PLATT DAVID by NDPD Pharma, Inc. BIXT common G - Gift I 0.0030 -411,300 -1 2,197,565
2023-02-08 2022-12-31 5 PLATT DAVID by NDPD Pharma, Inc. BIXT common I - Other I 0.0020 1,900,266 4 4,097,831
2023-02-08 2020-01-07 5 PLATT DAVID by spouse BIXT common G - Gift I 0 411,300
2023-02-08 2018-09-21 5 PLATT DAVID BIXT common A - Award D 0 43,027,274
2023-02-08 2022-12-31 5 Sheikh Michael by NDPD Pharma, Inc. BIXT common I - Other I 0.0020 -559,517 -1 0
2023-02-08 2022-12-31 5 Soderquist Ola by NDPD Pharma, Inc. BIXT common I - Other I 0.0020 -1,340,749 -3 0
2023-02-08 2022-12-20 5 Chen-Walden Hana BIXT common A - Award D 0.4060 20,000 8 347,800
2023-02-07 2022-12-20 5 CONAWAY DALE H BIXT common A - Award D 0.4060 20,000 8 440,800
2023-02-07 2022-12-20 5 Utter Anders BIXT Common A - Award D 0.4060 20,000 8 459,900
2023-02-07 2022-12-20 5 Hoberman Alan M BIXT Common A - Award D 0.4060 20,000 8 494,100
2022-08-16 2022-08-16 4 PLATT DAVID Through NDPD Pharma, Inc. BIXT Common stock D - Sale to Issuer I 0.0010 455,669 0 45,962,806
2022-08-05 2022-08-04 4 CONAWAY DALE H BIXT Common Stock A - Award D 0.2300 50,000 12 420,800
2022-08-05 2022-08-05 4 Chen-Walden Hana BIXT Common Stock A - Award D 0.2300 50,000 12 327,800
2022-08-05 2022-08-04 4 Hoberman Alan M BIXT Common Stock A - Award D 0.2300 50,000 12 494,100
2022-08-05 2022-08-04 4 Utter Anders BIXT Common Stock A - Award D 0.2300 50,000 12 439,900
2022-05-13 2022-05-11 4 Soderquist Ola by NDPD Pharma, Inc. BIXT Warrants G - Gift I 2.00 0.3600 -100,000 -36 0
2022-05-13 2022-05-11 4 Sheikh Michael by NDPD Pharma, Inc. BIXT Warrants G - Gift I 2.00 0.3600 -50,000 -18 0
2022-05-13 2022-05-11 4 PLATT DAVID by NDPD Pharma, Inc. BIXT Warrants G - Gift I 2.00 0.3600 -122,000 -44 0
2022-04-07 2022-04-05 4 Soderquist Ola BIXT Common G - Gift D 0.0010 -550,000 -1 19,585,300
2022-01-28 2021-12-03 5 Soderquist Ola by NDPD Pharma, Inc. BIXT Common A - Award I 0.0020 1,340,749 3 21,476,049
2022-01-28 2021-11-18 5 Soderquist Ola BIXT Common G - Gift D 0.1380 -3,201,788 -442 20,135,300
2022-01-28 2021-06-04 5 Soderquist Ola BIXT Common A - Award D 0.1300 2,973,988 387 23,337,088
2022-01-28 2021-05-02 5 Soderquist Ola by NDPD Pharma, Inc. BIXT Warrant A - Award I 2.00 0.3600 100,000 36 100,000
2022-01-28 2021-01-15 5 Soderquist Ola BIXT Common A - Award D 0.2400 227,800 55 20,363,100
2022-01-28 2021-01-15 5 OFFER BINDER BIXT Common A - Award D 0.2400 -227,800 -55 8,919,169
2022-01-28 2021-12-03 5 Sheikh Michael By NDPD Pharma, Inc. BIXT Common A - Award I 0.0020 599,517 1 559,517
2022-01-28 2021-11-19 5 Sheikh Michael By Resources Unlimited LLC BIXT Common G - Gift I 0.4820 -400,000 -193 8,800,000
2022-01-28 2021-11-19 5 Sheikh Michael BIXT Common G - Gift D 0.1430 -1,871,085 -268 9,200,000
2022-01-28 2021-06-04 5 Sheikh Michael BIXT Common A - Award D 0.1300 1,643,285 214 11,071,085
2022-01-28 2021-05-02 5 Sheikh Michael by NDPD Pharma, Inc. BIXT Warrants A - Award I 2.00 0.3600 50,000 18 50,000
2022-01-28 2021-01-15 5 Sheikh Michael BIXT Common A - Award D 0.2400 227,800 55 9,427,800
2022-01-28 2021-11-29 5 Chen-Walden Hana BIXT Common A - Award D 0.0010 30,000 0 277,800
2022-01-28 2021-12-03 5 PLATT DAVID by NDPD Pharma, Inc. BIXT Common A - Award I 0.0020 2,068,563 4 45,507,137
2022-01-28 2021-11-19 5 PLATT DAVID BIXT Common G - Gift D 0.1380 -3,201,788 -442 43,438,574
2022-01-28 2021-06-04 5 PLATT DAVID BIXT Common A - Award D 0.1300 2,973,988 387 46,640,362
2022-01-28 2021-05-02 5 PLATT DAVID by NDPD Pharma, Inc. BIXT Warrants A - Award I 2.00 0.3600 122,000 44 122,000
2022-01-28 2021-01-15 5 PLATT DAVID BIXT Common A - Award D 0.2400 227,800 55 43,666,374
2022-01-28 2021-11-29 5 CONAWAY DALE H BIXT Common A - Award D 0.0020 80,000 0 370,800
2022-01-28 2021-04-02 5 CONAWAY DALE H BIXT Common A - Award D 0.1700 30,000 5 290,800
2022-01-28 2021-01-18 5 CONAWAY DALE H BIXT Common A - Award D 0.2400 227,800 55 260,800
2022-01-28 2021-11-29 5 Utter Anders BIXT Common A - Award D 0.0010 80,000 0 389,900
2022-01-28 2021-04-02 5 Utter Anders BIXT Common A - Award D 0.1700 30,000 5 309,900
2022-01-28 2021-01-18 5 Utter Anders BIXT Common A - Award D 0.2400 227,800 55 279,900
2022-01-28 2021-11-29 5 Hoberman Alan M BIXT Common A - Award D 0.0010 80,000 0 444,100
2022-01-28 2021-04-02 5 Hoberman Alan M BIXT Common A - Award D 0.1700 30,000 5 364,100
2022-01-28 2021-01-18 5 Hoberman Alan M BIXT Common A - Award D 0.2400 227,800 55 334,100
2022-01-28 2021-11-29 4 Chen-Walden Hana BIXT Common A - Award D 0.0010 30,000 0 277,800
2022-01-27 3 Chen-Walden Hana BIXT Common D 247,800
2022-01-18 2021-12-03 4 Soderquist Ola by NDPD Pharma, Inc. BIXT Common A - Award I 0.0020 1,340,749 3 1,340,749
2022-01-18 2021-11-19 4 Soderquist Ola BIXT Common G - Gift D 0.1380 -3,201,788 -442 23,337,088
2022-01-18 2021-05-02 4 Soderquist Ola by NDPD Pharma, Inc. BIXT Warrants A - Award I 2.00 0.3600 100,000 36 100,000
2022-01-18 2021-12-03 4 Sheikh Michael by NDPD Pharma, Inc BIXT Common A - Award I 0.0020 599,517 1 599,517
2022-01-18 2021-11-19 4 Sheikh Michael by Resources UUnlimited LLC BIXT Common G - Gift I 0.4820 -400,000 -193 0
2022-01-18 2021-11-19 4 Sheikh Michael BIXT Common G - Gift D 0.1430 -1,871,085 -268 8,800,000
2022-01-18 2021-05-02 4 Sheikh Michael by NDPD Pharma, Inc. BIXT Warrants A - Award I 2.00 0.3600 50,000 18 50,000
2022-01-18 2021-12-03 4 PLATT DAVID by NDPD Pharma, Inc. BIXT Common A - Award I 0.0020 2,068,563 4 2,068,563
2022-01-18 2021-11-19 4 PLATT DAVID BIXT Common G - Gift D 0.1380 -3,201,788 -442 43,027,274
2022-01-18 2021-05-02 4 PLATT DAVID by NDPD Pharma, Inc. BIXT Warrants A - Award I 2.00 0.3600 122,000 44 122,000
2022-01-18 2021-11-29 4 CONAWAY DALE H BIXT Common A - Award D 0.0010 80,000 0 370,800
2022-01-18 2021-04-02 4 CONAWAY DALE H BIXT Common A - Award D 0.1700 30,000 5 290,800
2022-01-18 2021-11-29 4 Utter Anders BIXT Common A - Award D 0.0010 80,000 0 389,900
2022-01-18 2021-04-02 4 Utter Anders BIXT Common A - Award D 0.1700 30,000 5 309,900
2022-01-18 2021-11-29 4 Hoberman Alan M BIXT Common A - Award D 0.0010 80,000 0 444,100
2022-01-18 2021-04-02 4 Hoberman Alan M BIXT Common A - Award D 0.1700 30,000 5 364,100
2021-06-07 2021-06-04 4 Soderquist Ola BIXT Common J - Other D 0.1300 2,973,988 387 23,337,088
2021-06-07 2021-06-04 4 Sheikh Michael BIXT Common J - Other D 0.1300 1,643,285 214 10,671,085
2021-06-07 2021-06-04 4 PLATT DAVID BIXT Common J - Other D 0.1300 2,973,988 387 46,229,062
2021-01-19 2021-01-15 4 Sheikh Michael BIXT Common A - Award D 0.2400 227,800 55 9,027,800
2021-01-19 2021-01-15 4 Utter Anders BIXT Common A - Award D 0.2400 227,800 55 279,900
2021-01-19 2021-01-15 4 CONAWAY DALE H BIXT Common A - Award D 0.2400 227,800 55 260,800
2021-01-19 2021-01-15 4 Hoberman Alan M BIXT Common A - Award D 0.2400 227,800 55 334,100
2021-01-19 2021-01-15 4 OFFER BINDER BIXT Common A - Award D 0.2400 227,800 55 8,919,169
2021-01-19 2021-01-15 4 PLATT DAVID BIXT Common A - Award D 0.2400 227,800 55 43,255,074
2021-01-19 2021-01-15 4 Soderquist Ola BIXT Common A - Award D 0.2400 227,800 55 20,363,100
2021-01-04 2020-11-16 5 Hoberman Alan M BIXT Common A - Award D 0.0060 22,000 0 106,300
2021-01-04 2020-11-16 5 CONAWAY DALE H BIXT Common A - Award D 0.0060 22,000 0 33,000
2021-01-04 2020-11-16 5 Utter Anders BIXT Common A - Award D 0.0060 22,000 0 52,100
2021-01-04 2020-12-15 5 Soderquist Ola BIXT Common G - Gift D 0.0010 -947,263 -1 20,135,300
2021-01-04 2020-01-07 5 Soderquist Ola BIXT Common G - Gift D 0.0010 -864,700 -1 21,082,563
2021-01-04 2020-01-07 5 PLATT DAVID By Spouse BIXT Common G - Gift I 0.0010 411,300 0 411,300
2021-01-04 2020-01-07 5 PLATT DAVID BIXT Common G - Gift D 0.0010 -864,700 -1 43,027,274
2021-01-04 2020-01-10 5 OFFER BINDER BIXT Common G - Gift D 0.0010 -90,600 -0 8,691,369
2020-12-16 2020-12-16 4 Soderquist Ola BIXT Common G - Gift D 0.0010 -947,263 -1 20,135,300
2020-12-14 2020-11-16 4 Hoberman Alan M BIXT Common A - Award D 0.0060 22,000 0 106,300
2020-12-14 2020-11-16 4 Utter Anders BIXT Common A - Award D 0.0060 -22,000 -0 52,100
2020-12-14 2020-11-16 4 CONAWAY DALE H BIXT Common A - Award D 0.0060 -22,000 -0 33,000
2020-07-16 3 Utter Anders BIXT Common D 60,200
2020-07-16 3 Utter Anders BIXT Common D 60,200
2020-07-16 3 Utter Anders BIXT Common D 60,200
2020-07-13 3 CONAWAY DALE H BIXT Common D 22,000
2020-07-13 3 CONAWAY DALE H BIXT Common D 22,000
2020-07-13 3 CONAWAY DALE H BIXT Common D 22,000
2020-07-13 3 Hoberman Alan M BIXT Common D 168,600
2020-07-13 3 Hoberman Alan M BIXT Common D 168,600
2020-07-13 3 Hoberman Alan M BIXT Common D 168,600
2020-06-15 3 Sheikh Michael by Resources Unlimited, LLC BIXT Common I 9,600,200
2020-06-15 3 Sheikh Michael BIXT Common D 18,000,400
2020-06-15 3 Sheikh Michael by Resources Unlimited, LLC BIXT Common I 9,600,200
2020-06-15 3 Sheikh Michael BIXT Common D 18,000,400
2020-06-15 3 Sheikh Michael by Resources Unlimited, LLC BIXT Common I 9,600,200
2020-06-15 3 Sheikh Michael BIXT Common D 18,000,400
2020-01-10 2020-01-10 4 OFFER BINDER BIXT Common G - Gift D 0.0010 -90,600 -0 8,691,369
2020-01-07 2020-01-07 4 PLATT DAVID BIXT Common G - Gift D 0.0010 -864,700 -1 43,027,274
2020-01-07 2020-01-07 4 Soderquist Ola BIXT Common G - Gift D 0.0010 -864,700 -1 21,082,563
2018-09-27 3 OFFER BINDER USMN Common D 17,563,938
2018-09-27 3 OFFER BINDER USMN Common D 17,563,938
2018-09-27 3 OFFER BINDER USMN Common D 17,563,938
2018-09-27 3 PLATT DAVID USMN Common D 87,783,948
2018-09-27 3 PLATT DAVID USMN Common D 87,783,948
2018-09-27 3 PLATT DAVID USMN Common D 87,783,948
2018-09-27 3 Soderquist Ola USMN Common D 43,894,526
2018-09-27 3 Soderquist Ola USMN Common D 43,894,526
2018-09-27 3 Soderquist Ola USMN Common D 43,894,526
2018-09-24 2018-09-21 4/A AFCC, LLC USMN Common Stock, $0.001 par value D - Sale to Issuer D -71,150,000 2,350,000
2017-12-20 3 Marks Nathan USMN Common Stock, $0.001 par value D 3,008,326
2017-12-20 3 Marks Nathan USMN Common Stock, $0.001 par value D 3,008,326
2017-12-13 3 Farber Dave Quincy USMN Common Stock, $0.001 par value D 7,200,000
2017-12-13 3 Farber Dave Quincy USMN Common Stock, $0.001 par value D 7,200,000
2017-12-12 3 Lee David USMN Common Stock, $0.001 par value D 3,204,000
2017-12-12 3 Lee David USMN Common Stock, $0.001 par value D 3,204,000
2017-12-11 3 Bonafide Lawrence W. USMN Common Stock, $0.001 par value D 8,753,716
2017-12-11 3 Bonafide Lawrence W. USMN Common Stock, $0.001 par value D 8,753,716
2017-12-11 3 Kendig Donita R. USMN Common Stock, $0.001 par value D 7,500,000
2017-12-11 3 Kendig Donita R. USMN Common Stock, $0.001 par value D 7,500,000
2017-12-06 3 AFCC, LLC USMN Common Stock, $0.001 par value D 147,000,000
2017-12-06 3 AFCC, LLC USMN Common Stock, $0.001 par value D 147,000,000
2014-03-21 2014-03-17 4 HAIT PAUL W USMN Common Stock S - Sale D 0.0400 -95,225 -4 21,567,769
2014-03-21 2014-03-14 4 HAIT PAUL W USMN Common Stock S - Sale D 0.0400 -4,775 -0 21,662,994
2013-11-25 2013-11-15 4 HAIT PAUL W USMN U.S. Rare Earth Minerals Common Stock S - Sale D 0.0958 -54,953 -5 21,722,722
2013-11-12 2013-10-21 4 HAIT PAUL W USMN U.S. RARE EARTH MINERALS S - Sale D 0.1000 -100,000 -10 13,819,103
2013-03-18 2012-08-07 4 Hait Paul W. USMN Common Stock A - Award D -21,877,675 1,791,776
2013-03-18 2012-08-07 4 Hait Paul W. USMN Common Stock A - Award D 0.0250 -3,774,618 -94 23,669,451
2012-08-07 2012-08-07 4 Hait Paul W. USMN Common Stock A - Award D 0.2500 -3,774,618 -944 23,669,451
2012-08-07 2011-12-12 4 Hait Paul W. USMN Common Stock G - Gift D -890,667 19,894,833
2012-08-07 2012-08-07 4 Cullison Dennis USMN Common Stock A - Award D 0.0250 3,868,618 97 22,769,118
2012-08-07 2011-12-21 4 Cullison Dennis USMN Common Stock G - Gift D -3,250,000 18,900,500
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista